Tissue Regenix Group (TRX:LSE) Investor Relations Material

Overview

TRX Gold Corporation, a Canadian company, is delving into the exploration, development, and production of mineral property interests in the United Republic of Tanzania. Its main focus is on discovering gold deposits. The Buckreef gold project is a core asset of the firm, with one Special Mining License spanning an area of 16.04 square kilometers and 12 Prospecting Licenses encompassing 98.19 square kilometers situated in north-central Tanzania. In May 2022, the firm rebranded from Tanzanian Gold Corporation to TRX Gold Corporation. Founded in 1990, the corporation is headquartered in Oakville, Canada.

Frequently Asked Questions

What is Tissue Regenix Group's ticker?

Tissue Regenix Group's ticker is TRX

What exchange is Tissue Regenix Group traded on?

The company's shares trade on the LSE stock exchange

Where are Tissue Regenix Group's headquarters?

They are based in Garforth, England

How many employees does Tissue Regenix Group have?

There are 51-200 employees working at Tissue Regenix Group

What is Tissue Regenix Group's website?

It is https://www.tissueregenix.com/

What type of sector is Tissue Regenix Group?

Tissue Regenix Group is in the Healthcare sector

What type of industry is Tissue Regenix Group?

Tissue Regenix Group is in the Biotechnology industry

Who are Tissue Regenix Group's peers and competitors?

The following five companies are Tissue Regenix Group's industry peers:

- Cool Company

- Alterity Therapeutics Limited

- Corbus Pharmaceuticals Holdings

- BeiGene, Ltd.

- Oramed Pharmaceuticals Inc.